EffRx is attending the BIO International Convention 2026. As one of the most influential global events for the biotechnology and life sciences community, BIO 2026 will take place from June 22–25 at the San Diego Convention Center, bringing together the global biotech ecosystem for four days of high-impact networking, partnering, and industry exchange.

Its program features more than 130 sessions across 18 focus areas, including Business Development and Investment; Emerging Opportunities in Global Markets; Value, Patient Access, and Reimbursement; AI and Digital Health; and Patient Advocacy, as well as opportunities to connect with innovators, investors, and industry leaders.

EffRx proactively seeks in-licensing opportunities for Europe in niche therapeutic areas, with primary interest in rare diseases, endocrinology, and musculoskeletal disorders, and will meet with prospective companies to discuss possible collaborations. EffRx is also looking for partners to commercialize osteoporosis products in the US, LATAM, and selected Asian territories such as South Korea.